Friend or Foe? The Role of Regulatory Relief in Drug Shortages
This article was originally published in The Gold Sheet
Executive Summary
FDA’s Janet Woodcock argues that strong enforcement prevents drug shortages, dismissing allegations that crackdown under Hamburg triggered shortage crisis. There is more agreement, however, on the role of other factors such as group purchasing organizations, or GPOs, in the crisis.